Protection against ferroptosis through maintaining homeostasis of docosahexaenoate-containing phospholipids
Molecular Cell · 2025
DOI: 10.1016/j.molcel.2025.08.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025. Verfasst von Yaqin Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Ferroptosis, Phospholipids, Docosahexaenoic Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIH National Institute of General Medical Sciences.
Abstract (Originalsprache)
Although polyunsaturated phospholipids are vital for cellular functions, their overaccumulation renders cells vulnerable to ferroptosis. It remains unclear how cells exposed to excess polyunsaturated fatty acids (PUFAs) prevent their over-incorporation into phospholipids. Here, we identified a mechanism by which ubiquitin regulatory X domain-containing protein 8 (UBXD8), a fatty acid (FA)-interacting protein, prevents overaccumulation of phospholipids containing docosahexaenoate (DHA), one of the most abundant PUFAs in mammalian cells. UBXD8 binds to and activates 1-acylglycerol-3-phosphate O-acyltransferase 3 (AGPAT3), which specifically incorporates DHA into phospholipids. Thus, cultured cells and mouse livers deficient in UBXD8 were resistant to ferroptosis because of reduced production of DHA-containing phospholipids. Excess unsaturated FAs, including DHA, through their interaction with UBXD8, disrupt the UBXD8/AGPAT3 complex, thereby inhibiting AGPAT3-catalyzed synthesis of DHA-containing phospholipids. This FA-sensing mechanism prevents overaccumulation of DHA-containing phospholipids in cells exposed to excess DHA, thus reducing the ferroptotic potency of DHA, a property that might contribute to the health benefits of this ω-3 PUFA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Thoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: jin.ye@utsouthwestern.edu.
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIH National Institute of General Medical Sciences
- National Institutes of Health
- NIDDK
Zitieren
APA
Deng, Y., Vale, G., Liang, Y., Cui, S., Xu, S., McDonald, J. G., & Ye, J. (2025). Protection against ferroptosis through maintaining homeostasis of docosahexaenoate-containing phospholipids. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.08.023
Vancouver
Deng Y, Vale G, Liang Y, Cui S, Xu S, McDonald JG, et al. Protection against ferroptosis through maintaining homeostasis of docosahexaenoate-containing phospholipids. Molecular Cell. 2025. doi:10.1016/j.molcel.2025.08.023
BibTeX
@article{Deng2025,
author = {Deng, Yaqin and Vale, Goncalo and Liang, Yonggang and Cui, Shaojie and Xu, Shimeng and McDonald, Jeffrey G and Ye, Jin},
title = {Protection against ferroptosis through maintaining homeostasis of docosahexaenoate-containing phospholipids},
journal = {Molecular Cell},
year = {2025},
doi = {10.1016/j.molcel.2025.08.023}
}
EUVIMED